Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,460 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Parameters of a severe disease course in ulcerative colitis.
Stallmach A, Nickel L, Lehmann T, Bokemeyer B, Bürger M, Hüppe D, Kruis W, Nikolaus S, Preiss JC, Sturm A, Teich N, Schmidt C. Stallmach A, et al. Among authors: schmidt c. World J Gastroenterol. 2014 Sep 21;20(35):12574-80. doi: 10.3748/wjg.v20.i35.12574. World J Gastroenterol. 2014. PMID: 25253960 Free PMC article.
Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case Series.
Vavricka SR, Greuter T, Scharl M, Mantzaris G, Shitrit AB, Filip R, Karmiris K, Thoeringer CK, Boldys H, Wewer AV, Yanai H, Flores C, Schmidt C, Kariv R, Rogler G, Rahier JF; ECCO CONFER investigators. Vavricka SR, et al. Among authors: schmidt c. J Crohns Colitis. 2015 Oct;9(10):886-90. doi: 10.1093/ecco-jcc/jjv128. Epub 2015 Jul 17. J Crohns Colitis. 2015. PMID: 26188351
Vedolizumab for the treatment of ulcerative colitis.
Stallmach A, Schmidt C, Teich N. Stallmach A, et al. Among authors: schmidt c. Expert Rev Gastroenterol Hepatol. 2016;10(2):165-75. doi: 10.1586/17474124.2016.1123618. Epub 2015 Dec 15. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26588993 Review.
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, Hartmann F, Neurath MF, Maul J, Preiss JC, Schmelz R, Siegmund B, Schulze H, Teich N, von Arnim U, Baumgart DC, Schmidt C. Stallmach A, et al. Among authors: schmidt c. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1199-1212. doi: 10.1111/apt.13813. Epub 2016 Oct 7. Aliment Pharmacol Ther. 2016. PMID: 27714831
5,460 results